Viking Therapeutics (VKTX) Misses Q4 EPS by 4c
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.